Biotech

All Articles

Sanofi pays $110M upfront for late-stage radioligand therapy

.Sanofi has brought in a late access to the radioligand event, spending one hundred million european...

F 2G rears $100M for 2nd try to receive new antifungal to market

.After F2G's first attempt to acquire a brand-new training class of antifungal to market was wrecked...

Moderna targets $1.1 B in R&ampD costs slices, drops 5 plans surrounded by success stress

.Moderna has promised to cut R&ampD spending by $1.1 billion by 2027. The decision to retract the bu...

Sanofi's $80M bet on Key dystrophy medicine finishes in stage 3 go under

.Just four months after Sanofi bet $80 million in beforehand cash on Key Therapies' losmapimod, the ...

Oncternal share sinks 60% amidst layoffs, test terminations

.Cancer cells company Oncternal Therapies is folding all its scientific tests and also giving up tea...

Roche is actually keeping out hopes that its own injectable weight problems possibility could ultimately display 25% weight loss in late-stage trial

.Roche is holding out hopes that its injectable excessive weight prospect might at some point demons...

Novo Nordisk hails 'outstanding' fat loss result for dual-acting oral drug in early test

.Novo Nordisk has actually lifted the top on a period 1 trial of its oral amylin and also GLP-1 rece...

AbbVie files a claim against BeiGene over blood cancer cells medicine secret method

.Only a handful of short full weeks after winning an FDA Fast lane tag for its investigational BTK d...

Lilly supplies one-two punch along with 2nd tranche of favorable information on regular the hormone insulin applicant

.Soon after a positive information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based prov...

BridgeBio cuts gene therapy budget plan as medical records dissatisfy

.BridgeBio Pharma is actually slashing its own genetics therapy budget plan and drawing back from th...